Malaria prophylaxis policy for travellers from Europe to the Indian Sub Continent

Abstract Analysis of malaria imported into eight European countries from the Indian sub-continent (ISC) (India, Pakistan, Bangladesh and Sri Lanka) led to a consensus statement on the use of chemoprophylaxis within TropNetEurop. The proportion of cases from the ISC in 2004 ranged from 1.4%–4.6% of t...

Full description

Bibliographic Details
Published in:Malaria Journal
Main Authors: Jelinek T, Hatz C, Gascon J, Björkman A, Bisoffi Z, Behrens RH, Legros F, Mühlberger N, Voltersvik P
Format: Article in Journal/Newspaper
Language:English
Published: BMC 2006
Subjects:
Arctic medicine. Tropical medicine
RC955-962
Infectious and parasitic diseases
RC109-216
Arctic
Indian
Online Access:https://doi.org/10.1186/1475-2875-5-7
https://doaj.org/article/f7bb197e8d004810b171679938aa8b30
Description
Summary:Abstract Analysis of malaria imported into eight European countries from the Indian sub-continent (ISC) (India, Pakistan, Bangladesh and Sri Lanka) led to a consensus statement on the use of chemoprophylaxis within TropNetEurop. The proportion of cases from the ISC in 2004 ranged from 1.4%–4.6% of total imported cases. Plasmodium falciparum cases reported from the eight countries was only 23 (13% of all cases from the region). Total malaria reports between 1999–2004 fell from 317 to 180. The risk of malaria in UK residents visiting the region was > 1 case per 1,000 years exposed. The group recommended non-selective prescribing of chemoprophylaxis for visitors to India, Pakistan, Bangladesh and Sri Lanka should be dropped.

Similar Items